Abiomed
(NASDAQ) ABMD
Abiomed Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.07B
Net Income (TTM)
$266.76M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ABMD News
ABMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abiomed
Industry
{'id': 40, 'name': 'Healthcare Equipment and Supplies'}
Employees
2,003
CEO
Michael R. Minogue, MBA
Website
www.abiomed.comHeadquarters
Danvers, MA 01923, US
ABMD Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
36%
Net Income Margin
13%
Return on Equity
10%
Return on Capital
24%
Return on Assets
8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$843.60M
Operating Income
$372.69M
EBITDA
$500.46M
Operating Cash Flow
$285.39M
Capital Expenditure
$35.76M
Free Cash Flow
$249.63M
Cash & ST Invst.
$758.61M
Total Debt
$0.00
Abiomed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$265.92M
+7.2%
Gross Profit
$217.04M
+6.3%
Gross Margin
81.62%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2,003
N/A
Net Income
$106.13M
+86.4%
EBITDA
$226.14M
+240.4%
Quarterly Fundamentals
Net Cash
$820.37M
+26.1%
Accounts Receivable
$94.47M
+5.5%
Inventory
$102.24M
+18.9%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
8.16%
N/A
Return on Invested Capital
24.28%
N/A
Free Cash Flow
$7.81M
-85.4%
Operating Cash Flow
$13.42M
-77.8%